Search Results - "Caffier, H."

Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b as serum marker of bone metastases in human breast cancer by Capeller, B, Caffier, H, Sütterlin, M W, Dietl, J

“…The osteoclast-specific active TRAP 5b isoform is detectable in serum and claimed to be a specific marker of bone resorption. The present study was undertaken…”
Get more information

Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer by Oehler, M K, Caffier, H

“…The vascular endothelial growth factor (VEGF) is the angiogenic growth factor most strongly implicated in tumor angiogenesis. Its special role in the…”
Get more information

Diagnostic value of serum VEGF in women with ovarian tumors by Oehler, M K, Caffier, H

“…Angiogenesis is necessary for growth and invasiveness of malignant tumors. Vascular endothelial growth factor (VEGF) is considered to play a key role in tumor…”
Get more information

Predictive value of CEA and CA 15-3 in the follow up of invasive breast cancer by Sütterlin, M, Bussen, S, Trott, S, Caffier, H

“…The clinical usefulness of tumor markers in the follow-up care of invasive breast cancer is controversial. In 1228 serum samples of 664 women with history of…”
Get more information

Estimation of Probability of Malignancy Using a Logistic Model Combining Physical Examination, Ultrasound, Serum CA 125, and Serum CA 72-4 in Postmenopausal Women with a Pelvic Mass: An International Multicenter Study by Schutter, E.M.J., Sohn, C., Kristen, P., Möbus, V., Crombach, G., Kaufmann, M., Caffier, H., Kreienberg, R., Verstraeten, A.A., Kenemans, P.

“…Background.To assess the differential diagnostic potential of physical examination, ultrasound, the serum CA 125 assay, and serum CA 72-4 assay, and the…”
Get full text

A case of metastasizing invasive hydatidiform mole. Is less--less good? Review of the literature with regard to adequate treatment by Honig, A, Rieger, L, Kristen, P, Eck, M, Frambach, T, Tschammler, A, Caffier, H, Dietl, J

“…Patients with invasive hydatidiform moles (IHM) have a good prognosis. Even if disease has spread, monocytostatic treatment might be sufficient if the…”
Get more information

Endometrial carcinoma: immunohistochemically detected proliferation index is a prognosticator of long-term outcome by Gassel, A M, Backe, J, Krebs, S, Schön, S, Caffier, H, Müller-Hermelink, H K

“…AIM: To test which immunohistochemically detected tumour parameters are predictive of outcome in endometrial carcinoma. METHODS: A retrospective study of 300…”
Get full text

A somatic truncating mutation in BRCA2 in a sporadic breast tumor by Weber, B H, Brohm, M, Stec, I, Backe, J, Caffier, H

Get full text

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials by Clarke, M, Collins, R, Darby, S, Davies, C, Elphinstone, P, Evans, V, Godwin, J, Gray, R, Hicks, C, James, S, MacKinnon, E, McGale, P, McHugh, T, Peto, R, Taylor, C, Wang, Y

“…In early breast cancer, variations in local treatment that substantially affect the risk of locoregional recurrence could also affect long-term breast cancer…”
Get full text

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials by Clarke, M, Collins, R, Darby, S, Davies, C

“…Quinquennial overviews (1985–2000) of the randomised trials in early breast cancer have assessed the 5 year and 10-year effects of various systemic adjuvant…”
Get full text

CASA and Ca 125 in diagnosis and follow-up of advanced ovarian cancer by Oehler, M K, Sütterlin, M, Caffier, H

“…CA 125 is the most important tumor marker in ovarian cancer. Due to its low specificity and the fact that some ovarian malignancies do not produce considerable…”
Get more information

The correlation of c-erbB-2 oncoprotein and established prognostic factors in human breast cancer by Sütterlin, M W, Haller, A, Gassel, A M, Peters, K, Caffier, H, Dietl, J

“…The c-erbB-2 (HER2/neu) receptor is a transmembrane phosphoglycoprotein associated with multiple signal transduction pathways. Its overexpression in breast…”
Get more information

Cyclin-dependent kinase inhibitor p21 in endometrial carcinoma by Backe, J, Caffier, H, Dietl, J

Get full text

Correlation of the EGF-receptor with cell kinetic and classical prognostic factors in breast cancer by Oehler, M K, Rehn, M, Kristen, P, Sütterlin, M, Caffier, H

“…The Epidermal Growth Factor Receptor (EGFR) is a specific cell membrane receptor that shows homology to the product of the oncogene c-erbB2 in human breast…”
Get more information

Adjuvant randomized trials of doxorubicin/cyclophosphamide versus doxorubicin/cyclophosphamide/tamoxifen and CMF chemotherapy versus tamoxifen in women with node-positive breast cancer by Kaufmann, M, Jonat, W, Abel, U, Hilfrich, J, Caffier, H, Kreienberg, R, Trams, G, Brunnert, K, Schermann, J, Kleine, W

“…We report two randomized trials of adjuvant systemic therapy in 747 patients < or = 65 years of age with histologically proven node-positive breast cancer…”
Get more information

Immunohistochemically detected HER-2/neu-expression and prognosis in endometrial carcinoma by Backe, J, Gassel, A M, Krebs, S, Müller, T, Caffier, H

“…Expression of the HER-2/neu proto-oncogene product was looked for immunohistochemically in 222 endometrial carcinomas in a retrospective follow-up study. The…”
Get full text

Prognostic relevance of p53 in node negative breast cancer by Kristen, P, Müller, J G, Caffier, H

“…In a retrospective study, immunohistochemical determinations of p53 were performed on paraffinised tissue sections of 243 patients with node negative breast…”
Get more information

Clinical value of CYFRA 8/18 and TPS in the diagnosis and follow up of invasive breast cancer by Sütterlin, M, Oehler, M K, Caffier, H

“…In a prospective study, we evaluated the diagnostic accuracy of CYFRA 8/18, TPS, CEA and CA 15-3 among 415 patients in various clinical situations of invasive…”
Get more information

The endothelial marker CD 34 in the assessment of tumour vascularisation in ovarian cancer by Heimburg, S, Oehler, M K, Kristen, P, Papadopoulos, T, Caffier, H

“…Tumour angiogenesis as well as the density of newly formed vessels are of potential prognostic relevance in the assessment of malignant neoplasia. Among other…”
Get more information

Sex hormone binding and peritumoural oedema in meningiomas : is there a correlation ? by MEIXENSBERGER, J, CAFFIER, H, NAUMANN, M, HOFMANN, E

“…Steroid receptor binding activity was evaluated in specimens of 28 human cerebral meningiomas using a dextran coated charcoal (DCC) assay. Oestrogen receptor…”
Get full text